ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
Source: SeekingAlpha
2026-02-01 00:54:11 ET
Intro
ResMed ( RMD ) is a $37 billion powerhouse that sees itself as a "36-year-old startup" in the field of sleep and breathing health. It dominates as the #1 provider in 140+ countries with a 50–60% market share in sleep apnea devices like CPAP (“Continuous Positive Airway Pressure”) machines, masks, and SaaS platforms/digital solutions. The company targets obstructive sleep apnea (OSA) and COPD for better rest and vitality....
Read the full article on Seeking Alpha
For further details see:
ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
ResMed Inc.
NASDAQ: RMD
RMD Trading
-0.68% G/L:
$231.89 Last:
430,848 Volume:
$234.89 Open:
RMD Latest News
March 03, 2026 03:00:00 am
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
February 24, 2026 09:00:00 am
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
January 29, 2026 04:05:00 pm
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
RMD Stock Data
$39,533,476,071
144,731,491
0.09%
478
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
